---
title: "Kingchem: The nationality of the actual controller does not affect the normal operation and business development of the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232700413.md"
description: "An investor asked Kingchem on the interactive platform: The actual controller of the company is a Chinese American. Does the American nationality of the actual controller have any exemption under the U.S. Biological Safety Act? Kingchem replied that the U.S. Biological Safety Act is still in the legislative process, and the company has not been included in the restricted list of that act. As a company registered and listed in China, the nationality of the actual controller does not affect the normal operation and business development of the company. The company will continue to monitor and assess the progress of the act and its potential uncertainties"
datetime: "2025-03-21T07:56:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232700413.md)
  - [en](https://longbridge.com/en/news/232700413.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232700413.md)
generator: "portal-rs"
---

# Kingchem: The nationality of the actual controller does not affect the normal operation and business development of the company

On March 21st, Jin10 Data reported that an investor asked Kingchem on an interactive platform: "The actual controller of the company is a Chinese American. Does the American nationality of the actual controller have any exemption under the U.S. Biological Safety Act?" Kingchem responded that the U.S. Biological Safety Act is still in the legislative process, and the company is not listed on the restriction list of that act. As a company registered and listed in China, the nationality of the actual controller does not affect the normal operation and business development of the company. The company will continue to monitor and assess the progress of the act and its uncertain impacts

### Related Stocks

- [301509.CN](https://longbridge.com/en/quote/301509.CN.md)

## Related News & Research

- [Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio | RVVTF Stock News](https://longbridge.com/en/news/296357987.md)
- [Wolfden says bio-oxidation lifts Canoe Landing gold recovery to 60% from 32%](https://longbridge.com/en/news/296340376.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [14:17 ETEnzymedica Launches Phytosome® Formulas for Sleep, Stress and Whole-Body Comfort*](https://longbridge.com/en/news/296388269.md)
- [22:15 ETConférence mondiale sur la robotique 2026 : Zoomlion présente l'intelligence intégrée dans le secteur industriel](https://longbridge.com/en/news/296662710.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**